85 related articles for article (PubMed ID: 10489166)
1. Infrequent genetic alterations of p53, p16 genes and polymorphism in fhit gene in Indian myelodysplastic syndrome.
Kannan K; Tharu R; Gopinath PM; Bharadwaj TP; Munirajan AK; Tsuchida N; Shanmugam G
Oncol Res; 1999; 11(2):101-4. PubMed ID: 10489166
[TBL] [Abstract][Full Text] [Related]
2. [Alterations of FHIT gene and p16 gene in lung cancer and metastatic hilar lymph nodes].
Wang X; Sun Y; Li W
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):108-11. PubMed ID: 11776848
[TBL] [Abstract][Full Text] [Related]
3. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
4. Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst.
Malcić A; Jukić S; Anić I; Pavelić B; Kapitanović S; Kruslin B; Pavelić K
J Oral Pathol Med; 2008 May; 37(5):294-301. PubMed ID: 18221322
[TBL] [Abstract][Full Text] [Related]
5. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
[TBL] [Abstract][Full Text] [Related]
7. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
[TBL] [Abstract][Full Text] [Related]
8. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
9. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
10. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
11. [Alteration of FHIT gene and p16 gene in malignant transformed cells induced by crystalline nickel sulfide].
Ji WD; Wu ZL; Chen JK; Yi F; Feng SM
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):26-30. PubMed ID: 12678982
[TBL] [Abstract][Full Text] [Related]
12. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
13. Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome.
Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Milasin J; Bunjevacki G; Damnjanovic T; Cvjeticanin S; Bunjevacki V
Cancer Genet Cytogenet; 2006 Apr; 166(2):163-5. PubMed ID: 16631474
[TBL] [Abstract][Full Text] [Related]
14. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
[TBL] [Abstract][Full Text] [Related]
15. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
16. Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.
Preudhomme C; Lubin R; Lepelley P; Vanrumbeke M; Fenaux P
Leukemia; 1994 Sep; 8(9):1589-91. PubMed ID: 8090036
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
[TBL] [Abstract][Full Text] [Related]
18. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH
Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.
Bradley G; Irish J; MacMillan C; Mancer K; Witterick I; Hartwick W; Gullane P; Kamel-Reid S; Benchimol S
Oncogene; 2001 Feb; 20(5):654-8. PubMed ID: 11313998
[TBL] [Abstract][Full Text] [Related]
20. [Mutations of several tumor suppressor genes in primary retinoblastoma].
Huang Q; Tao Y; Yandell DW
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
